Last reviewed · How we verify
NCT05388357: FLASH
AI Quantitative Coronary Angiography Versus Optical Coherent Tomography Guidance for Coronary Stent Implantation
NA trial testing Intervention Procedure: PCI in Coronary Vessels in 400 participants. Completed in 2 October 2024.
30 June 2024
Quick facts
| Lead sponsor | Asan Medical Center |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 400 |
| Start date | 4 October 2022 |
| Primary completion | 30 June 2024 |
| Estimated completion | 2 October 2024 |
| Sites | 13 locations across South Korea |
Drugs / interventions tested
- Intervention Procedure: PCI
Conditions studied
- Coronary Vessels — all drugs for Coronary Vessels →
- Procedure PCI — all drugs for Procedure PCI →
Sponsor
Asan Medical Center
Who can join
19 and older, any sex, with Coronary Vessels or Procedure PCI. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study is to establish the primary hypothesis thatAI -QCA guided PCI is non-inferior to Optical coherence tomography-guided Percutaneous coronary intervention regarding minimal Stent area by Final OCT and Procedural MACE
Publications & conference data
3 peer-reviewed publications reference this trial (live from Europe PMC):
-
Artificial Intelligence-Based Fully Automated Quantitative Coronary Angiography vs Optical Coherence Tomography-Guided PCI: The FLASH Trial.
Kim Y, Yoon HJ, Suh J, Kang SH, et al · · 2025 · cited 12× · PMID 39614852 · DOI 10.1016/j.jcin.2024.10.025 -
Fully automated quantitative coronary angiography versus optical coherence tomography guidance for coronary stent implantation (FLASH): Study protocol for a randomized controlled noninferiority trial.
Kim Y, Park H, Yoon HJ, Suh J, et al · · 2024 · cited 3× · PMID 38723880 · DOI 10.1016/j.ahj.2024.05.004 -
Quantitative Coronary Angiography Guidance for Drug-Eluting Stent Implantation: A Narrative Review.
Lee CW, Lee PH, Lee SW, Serruys PW. · · 2024 · PMID 39691560 · DOI 10.1002/hsr2.70286
Verify or expand the search:
- PubMed search for NCT05388357
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Coronary Vessels
Currently open trials in the same condition.
- NCT03394079 — Optical Coherence Tomography Versus Intravascular Ultrasound Guided Percutaneous Coronary Intervention · NA · active not recruiting
Other Asan Medical Center trials
Trials by the same sponsor.
- NCT07530393 — Blood Viscosity and Outcomes After Elective Craniotomy · not yet recruiting
- NCT07010497 — A Prospective Study to Evaluate the Safety and Efficacy of the Combination Therapy of Irpagratinib, Atezolizumab, and Be · Phase 2 · recruiting
- NCT07382505 — Prospective Cohort Study of Minimal Residual Disease(MRD) Testing for Early Recurrence Detection in Endometrial and Cerv · not yet recruiting
- NCT07489092 — Feasibility of a Digital Rehabilitation Platform in Patients After ICU Discharge · NA · recruiting
- NCT07431762 — Comparison of Anti-Thrombotic Treatments Between Aspirin and Warfarin During Initial Six Months After Bioprpsthetic Hear · Phase 4 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05388357 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Asan Medical Center
- Last refreshed: 24 October 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05388357.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing